EUVIMEDEUVIMED entdecken
Crossref

Fingolimod, an antagonist of sphingosine 1-phosphate, ameliorates Sjögren's syndrome by reducing the number of STAT3–induced germinal center B cells and increasing the number of Breg cells

Yeon Su Lee, JooYeon Jhun, Jeong Won Choi, Sun-Hee Hwang, Jin Seok Woo, Kun Hee Lee, Seung Cheon Yang, A Ram Lee, Mi-La Cho

Immunology Letters · 2024-12 · 270 · 106935

DOI: 10.1016/j.imlet.2024.106935 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology Letters, 2024-12. Verfasst von Yeon Su Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lab of Translational ImmunoMedicine (LaTIM), Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, S…. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Fingolimod Hydrochloride, Germinal Center, STAT3 Transcription Factor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromeFingolimod HydrochlorideGerminal CenterSTAT3 Transcription FactorSphingosineLysophospholipidsSalivary GlandsB-Lymphocytes, RegulatoryAnimalsMiceMice, Inbred NODFemaleDisease Models, AnimalB-LymphocytesHumans

Stichwörter der Autor:innen

FTY720FingolimodSignal transducer and activator of transcription (STAT)Sjögren's syndrome

Substanzen

Fingolimod HydrochlorideSTAT3 Transcription FactorSphingosinesphingosine 1-phosphateLysophospholipids

Autor:innen und Institutionen

  • Lab of Translational ImmunoMedicine (LaTIM), Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, 06591, South Korea; Department of Pathology, College of Medicine…
  • Lab of Translational ImmunoMedicine (LaTIM), Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, 06591, South Korea.

Zitieren

APA

Lee, Y. S., Jhun, J., Choi, J. W., Hwang, S. H., Woo, J. S., Lee, K. H., Yang, S. C., Lee, A. R., & Cho, M. L. (2024). Fingolimod, an antagonist of sphingosine 1-phosphate, ameliorates Sjögren's syndrome by reducing the number of STAT3–induced germinal center B cells and increasing the number of Breg cells. Immunology Letters, 270, 106935. https://doi.org/10.1016/j.imlet.2024.106935

Vancouver

Lee YS, Jhun J, Choi JW, Hwang SH, Woo JS, Lee KH, et al. Fingolimod, an antagonist of sphingosine 1-phosphate, ameliorates Sjögren's syndrome by reducing the number of STAT3–induced germinal center B cells and increasing the number of Breg cells. Immunology Letters. 2024;270:106935. doi:10.1016/j.imlet.2024.106935

BibTeX
@article{Lee2024,
  author = {Lee, Yeon Su and Jhun, JooYeon and Choi, Jeong Won and Hwang, Sun-Hee and Woo, Jin Seok and Lee, Kun Hee and Yang, Seung Cheon and Lee, A Ram and Cho, Mi-La},
  title = {Fingolimod, an antagonist of sphingosine 1-phosphate, ameliorates Sjögren's syndrome by reducing the number of STAT3–induced germinal center B cells and increasing the number of Breg cells},
  journal = {Immunology Letters},
  year = {2024},
  volume = {270},
  pages = {106935},
  doi = {10.1016/j.imlet.2024.106935}
}
Kostenlos starten →